Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Tegsedi (inotersen)
pCPA File Number:
21156
Negotiation Status:
Concluded with an LOI
Indication(s):
hereditary transthyretin-mediated amyloidosis
Sponsor/Manufacturer:
Akcea Therapeutics Inc.
CADTH Project Number:
SR0603-000
pCPA Engagement Letter Issued:
2019-11-29
Negotiation Process Concluded:
2020-04-30